Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

Husain I, Zameer S, Madaan T, Minhaj A, Ahmad W, Iqubaal A, Ali A, Najmi AK.

Metab Brain Dis. 2019 Aug;34(4):957-965. doi: 10.1007/s11011-019-00400-9. Epub 2019 Mar 8.

Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations

Kachian ZR, Cohen-Zimerman S, Bega D, Gordon B, Grafman J.

J Affect Disord. 2019 May 1;250:319-329. doi: 10.1016/j.jad.2019.03.043. Epub 2019 Mar 5.

Small molecules as therapeutic drugs for Alzheimer's disease

Oliver DMA, Reddy PH.

Mol Cell Neurosci. 2019 Apr;96:47-62. doi: 10.1016/j.mcn.2019.03.001. Epub 2019 Mar 12.

A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice

Wadrup F, Holden S, MacLeod R, Miedzybrodzka Z, Németh AH, Owens S, Pasalodos S, Quarrell O, Clarke AJ; UK Huntington’s Disease Predictive Testing Consortium.

Eur J Hum Genet. 2019 Aug;27(8):1215-1224. doi: 10.1038/s41431-019-0375-8. Epub 2019 Mar 19.

A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data

Patel H, Dobson RJB, Newhouse SJ.

J Alzheimers Dis. 2019;68(4):1635-1656. doi: 10.3233/JAD-181085.

Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders

Ullah MF, Ahmad A, Bhat SH, Abu-Duhier FM, Barreto GE, Ashraf GM.

Neurosci Biobehav Rev. 2019 Jul;102:95-105. doi: 10.1016/j.neubiorev.2019.04.003. Epub 2019 Apr 5.

Depression in neurodegenerative diseases: Common mechanisms and current treatment options

Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J.

Neurosci Biobehav Rev. 2019 Jul;102:56-84. doi: 10.1016/j.neubiorev.2019.04.002. Epub 2019 Apr 15.

Benefits of curcumin in brain disorders

Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, Padamati J, Chandra R, Chidambaram SB, Sakharkar MK.

Biofactors. 2019 Sep;45(5):666-689. doi: 10.1002/biof.1533. Epub 2019 Jun 11.

Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders

Rivera S, García-González L, Khrestchatisky M, Baranger K.

Cell Mol Life Sci. 2019 Aug;76(16):3167-3191. doi: 10.1007/s00018-019-03178-2. Epub 2019 Jun 13.

Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study

Shoulson I, Eberly S, Oakes D, Kayson E, Young AB; PHAROS Investigators.

Ann Clin Transl Neurol. 2019 May 1;6(6):1046-1052. doi: 10.1002/acn3.781. eCollection 2019 Jun.

Predicting the Risk of Huntington's Disease with Multiple Longitudinal Biomarkers

Li F, Li K, Li C, Luo S; PREDICT-HD and ENROLL-HD Investigators of the Huntington Study Group.

J Huntingtons Dis. 2019;8(3):323-332. doi: 10.3233/JHD-190345.

Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases

Zhang Q, Lei YH, Zhou JP, Hou YY, Wan Z, Wang HL, Meng H.

Neurochem Res. 2019 Sep;44(9):2031-2043. doi: 10.1007/s11064-019-02858-6. Epub 2019 Aug 13.

Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer's Disease

Dhakal S, Kushairi N, Phan CW, Adhikari B, Sabaratnam V, Macreadie I.

Int J Mol Sci. 2019 Oct 14;20(20):5090. doi: 10.3390/ijms20205090.

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases

Konovalova J, Gerasymchuk D, Parkkinen I, Chmielarz P, Domanskyi A.

Int J Mol Sci. 2019 Nov 30;20(23):6055. doi: 10.3390/ijms20236055.

Zinc transporters in Alzheimer's disease

Xu Y, Xiao G, Liu L, Lang M.

Mol Brain. 2019 Dec 9;12(1):106. doi: 10.1186/s13041-019-0528-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias